Physician profile
Beatrix Frasure
NPI 1811181837
$1,734.63
in general payments reported to CMS, 2019-2025
15 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $193 · 2022: $371 · 2023: $516 · 2024: $449 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $380.38 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $253.50 | 2021-2024 | Absorica Ld, Winlevi |
| Genzyme Corporation | $240.71 | 2021-2025 | |
| Lilly USA, LLC | $218.58 | 2022-2025 | Taltz, Ebglyss |
| Janssen Biotech, INC. | $171.83 | 2021-2023 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $137.91 | 2021-2025 | Libtayo, Dupixent |
| Allergan, INC. | $55.55 | 2022 | |
| Novartis Pharmaceuticals Corporation | $53.57 | 2024 | |
| Epi Health, LLC | $52.50 | 2022 | |
| Ucb, INC. | $51.78 | 2024 | Bimzelx |
| Amgen INC. | $32.05 | 2022-2024 | Otezla |
| Almirall LLC | $30.31 | 2023 | Seysara |
| Incyte Corporation | $23.67 | 2024 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.46 | 2024 | Cabtreo, Arazlo |
| Biofrontera INC. | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beatrix Frasure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.